For: | Xiong JH, Liu J, Chen J. Clinical significance and prognostic value of tumor necrosis factor-α and dickkopf related protein-1 in ankylosing spondylitis. World J Clin Cases 2020; 8(7): 1213-1222 [PMID: 32337195 DOI: 10.12998/wjcc.v8.i7.1213] |
---|---|
URL: | https://www.wjgnet.com/2307-8960/full/v8/i7/1213.htm |
Number | Citing Articles |
1 |
Zhenzhen Zhang, Jing Zeng, Yang Li, Qing Liao, Dongdong Huang, Yucong Zou, Gang Liu. Tail suspension delays ectopic ossification in proteoglycan‑induced ankylosing spondylitis in mice via miR‑103/DKK1. Experimental and Therapeutic Medicine 2021; 22(3) doi: 10.3892/etm.2021.10397
|
2 |
Sha-Sha Tao, Fan Cao, Napoleon Bellua Sam, Hong-Miao Li, Ya-Ting Feng, Jing Ni, Peng Wang, Xiao-Mei Li, Hai-Feng Pan. Dickkopf-1 as a promising therapeutic target for autoimmune diseases. Clinical Immunology 2022; 245: 109156 doi: 10.1016/j.clim.2022.109156
|
3 |
Haihuan Feng, Ying Zhao, Weihong Kuang, Yanping Dai, Xiaobo Cen, Feng Qin. Adverse events of tumor necrosis factor alpha inhibitors for the treatment of ankylosing spondylitis: A meta-analysis of randomized, placebo-controlled trials. Frontiers in Pharmacology 2023; 14 doi: 10.3389/fphar.2023.1084614
|
4 |
Jin-Xian Huang, Yung-Heng Lee, James Cheng-Chung Wei. Patient-tailored dose reduction of tumor necrosis factor inhibitors in axial spondyloarthritis. International Immunopharmacology 2023; 116: 109804 doi: 10.1016/j.intimp.2023.109804
|
5 |
M. A. Vorobyeva, E. A. Shatunova, K. I. Kolpakov, Yu. D. Kurochkina, M. A. Korolev. Clinical Diagnostic Value of Dkk-1 Level in Ankylosing Spondylitis: Comparison of Test Systems Based on Aptamers and Antibodies. Bulletin of Experimental Biology and Medicine 2022; 173(3): 317 doi: 10.1007/s10517-022-05541-z
|